Example: Heart Attack

Search clinical trials for: 1 alpha-hydroxyergocalciferol

Total 25 results

NCT00792857

Completed

Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)

Conditions: Chronic Kidney Disease; Secondary Hyperparathyroidism; Chronic Renal Insufficiency; Chronic Renal Failure
NCT00601107

Completed

A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis

Conditions: Moderate to Severe Chronic Plaque Psoriasis
NCT02859896

Recruiting

Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis

Conditions: Secondary Hyperparathyroidism-Chronic Kidney Disease
NCT00646282

Terminated

Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant Patients

Conditions: Hyperparathyroidism, Secondary
NCT00511017

Terminated

Doxercalciferol in Recurrent Pediatric Solid Tumors

Conditions: Solid Tumors
NCT00889629

Completed

Pilot Study Evaluating Doxercalciferol Replacement Therapy in Kidney Transplant Recipients

Conditions: Chronic Kidney Disease; Kidney Transplantation
NCT00418600

Completed

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

Conditions: Secondary Hyperparathyroidism
NCT00257920

Completed

A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease

Conditions: Chronic Kidney Disease, Stage 5; Secondary Hyperparathyroidism
NCT00285467

Completed

Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease

Conditions: Renal Osteodystrophy
NCT00052832

Completed

Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Conditions: Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
NCT00454350

Completed

A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis

Conditions: Secondary Hyperparathyroidism
NCT00463021

Completed

A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection

Conditions: Secondary Hyperparathyroidism
NCT00502268

Withdrawn

Vitamin D and Carboxy PTH Fragments in Coronary Calcification

Conditions: Coronary Calcification; Endstage Renal Disease; Parathyroid Hormone
NCT00123461

Completed

Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism

Conditions: Secondary Hyperparathyroidism; Renal Failure; Chronic Renal Insufficiency
NCT00528788

Completed

How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis

Conditions: Hyperparathyroidism, Secondary; Kidney Failure, Chronic
NCT00022412

Completed

Doxercalciferol Before Surgery in Treating Localized Prostate Cancer

Conditions: Prostate Cancer
NCT00582582

Terminated

Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer

Conditions: Prostate Cancer
NCT00749736

Completed

The Role of Vitamin D in Immune Function in Patients With Chronic Kidney Disease (CKD) Stages 3 and 4.

Conditions: Chronic Kidney Disease
NCT02282813

Completed

Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002

Conditions: Chronic Kidney Disease; Hyperparathyroidism, Secondary; Vitamin D Deficiency
NCT01100723

Completed

Trial to Optimize Mineral Outcomes in Dialysis Patients

Conditions: Secondary Hyperparathyroidism; Chronic Kidney Disease
NCT00135304

Completed

ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism

Conditions: Secondary Hyperparathyroidism
NCT00977080

Completed

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

Conditions: Chronic Kidney Disease; Secondary Hyperparathyroidism; Hemodialysis
NCT00560300

Completed

Regulation of Bone Formation in Renal Osteodystrophy

Conditions: Secondary Hyperparathyroidism; Renal Osteodystrophy
NCT01799317

Unknown status

How Bone is Made in Children Receiving Dialysis

Conditions: Bone Mineralization Defect
NCT01181531

Completed

Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis

Conditions: Hyperparathyroidism, Secondary